Medicure (OTCMKTS:MCUJF) Shares Up 26.8% – Should You Buy?

Medicure Inc. (OTCMKTS:MCUJF) traded up 26.8% on Friday . The company traded as high as $0.8554 and last traded at $0.8554. 10,020 shares were traded during mid-day trading, an increase of 500,900% from the average daily volume of 2 shares. The stock had previously closed at $0.6746.

Medicure Price Performance

The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.03. The stock’s 50-day moving average price is $0.75 and its 200-day moving average price is $0.81. The company has a market capitalization of $8.93 million, a price-to-earnings ratio of -1.82 and a beta of 1.02.

Medicure (OTCMKTS:MCUJF) last issued its quarterly earnings results on Thursday, May 21st. The company reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.01. Medicure had a negative net margin of 21.65% and a negative return on equity of 44.34%. The business had revenue of $5.79 million during the quarter, compared to analyst estimates of $3.63 million.

Medicure Company Profile

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.